Physician profile
Thomas Gregory Lang
NPI 1508159641
$1,709.21
in general payments reported to CMS, 2019-2025
20 companies · $58.84 in 2025
The $58.84 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $497 · 2020: $31.71 · 2021: $323 · 2022: $405 · 2023: $81.35 · 2024: $312 · 2025: $58.84.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $452.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $452.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $289.11 | 2019-2023 | |
| Coopersurgical, INC. | $269.09 | 2019-2024 | Summit Doppler |
| Hologic Sales and Service, LLC | $211.57 | 2019-2024 | Myosure Tissue Removal Device, Novasure, Acessa Provu System |
| Gynesonics, INC. | $171.24 | 2022 | |
| Medicem INC. | $115.57 | 2021 | |
| Meditrina | $84.85 | 2022 | |
| Evofem Biosciences, INC. | $81.92 | 2021 | |
| Avanos Medical | $76.91 | 2019 | |
| Baxter Healthcare | $76.37 | 2022 | |
| Mayne Pharma Commercial LLC | $73.19 | 2023-2024 | |
| Therapeuticsmd, INC. | $43.42 | 2019-2020 | |
| Astellas Pharma US INC | $31.81 | 2025 | Veozah |
| Shield Therapeutics INC | $30.42 | 2024 | |
| Pfizer INC. | $28.66 | 2023-2024 | |
| Exact Sciences Corporation | $27.03 | 2025 | The Cologuard Plus Collection Kit |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $22.79 | 2024 | Myfembree |
| Conmed Corporation | $21.74 | 2024 | Airseal |
| Daiichi Sankyo INC. | $20.43 | 2019 | |
| Allergan, INC. | $17.04 | 2019 | |
| Roche Diagnostics Corporation | $16.05 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Lang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.